Direct and indirect impacts of the COVID-19 pandemic on life expectancy and person-years of life lost with and without disability: A systematic analysis for 18 European countries, 2020–2022
PLOS Medicine · 2025
DOI: 10.1371/journal.pmed.1004541 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Medicine, 2025. Verfasst von Sara Ahmadi-Abhari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics (EBS), School of Public Health, Imperial College London, London, United Kingdom. Hauptthemen laut MEDLINE: Life Expectancy, COVID-19, Persons with Disabilities. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIA NIH HHS, Imperial College London.
Abstract (Originalsprache)
Background
The direct and indirect impacts of the COVID-19 pandemic on life expectancy (LE) and years of life lost with and without disability remain unclear. Accounting for pre-pandemic trends in morbidity and mortality, we assessed these impacts in 18 European countries, for the years 2020–2022. Methods and Findings We used multi-state Markov modeling based on several data sources to track transitions of the population aged 35 or older between eight health states from disease-free, combinations of cardiovascular disease, cognitive impairment, dementia, and disability, through to death. We quantified separately numbers and rates of deaths attributable to COVID-19 from those related to mortality from other causes during 2020–2022, and estimated the proportion of loss of life expectancy and years of life with and without disability that could have been avoided if the pandemic had not occurred. Estimates were disaggregated by COVID-19 versus non-COVID causes of deaths, calendar year, age, sex, disability status, and country. We generated the 95% uncertainty intervals (UIs) using Monte Carlo simulations with 500 iterations. Among the 289 million adult population in the 18 countries, person-years of life lost (PYLL) in millions were 4.7 (95% UI 3.4–6.0) in 2020, 7.1 (95% UI 6.6–7.9) in 2021, and 5.0 (95% UI 4.1–6.2) in 2022, totaling 16.8 (95% UI 12.0–21.8) million. PYLL per capita varied considerably between the 18 countries ranging between 20 and 109 per 1,000 population. About 60% of the total PYLL occurred among persons aged over 80, and 30% in those aged 65–80. If the pandemic were avoided, over half (9.8 million (95% UI 4.7–15.1)) of the 16.8 million PYLL were estimated to have been lived without disability. Of the total PYLL, 11.6–13.2 million were due to registered COVID-19 deaths and 3.6–5.3 million due to non-COVID mortality. Despite a decrease in PYLL attributable to COVID-19 after 2021, PYLL associated with other causes of death continued to increase from 2020 to 2022 in most countries. Lower income countries had higher PYLL per capita as well as a greater proportion of disability-free PYLL during 2020–2022. Similar patterns were observed for life expectancy. In 2021, LE at age 35 (LE-35) declined by up to 2.8 (95% UI 2.3–3.3) years, with over two-thirds being disability-free. With the exception of Sweden, LE-35 in the studied countries did not recover to 2019 levels by 2022.
Conclusions
The considerable loss of life without disability and the rise in premature mortality not directly linked to COVID-19 deaths during 2020–2022 suggest a potential broader, longer-term and partially indirect impact of the pandemic, possibly resulting from disruptions in healthcare delivery and services for non-COVID conditions and unintended consequences of COVID-19 containment measures. These findings highlight a need for better pandemic preparedness in Europe, ideally, as part of a more comprehensive global public health agenda.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics (EBS), School of Public Health, Imperial College London, London, United Kingdom.
- Department of Preventive Medicine and Education, Medical University of Gdansk, Gdansk, Poland.
- Department of Epidemiology and Public Health, University College London, London, United Kingdom.
- Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Broad Institute of MIT and Harvard, The Klarman Cell Observatory, Cambridge, Massachusetts, United States of America.
- MRC Centre for Environment and Health, Imperial College London, London, United Kingdom.
ORCID-Profile: Sara Ahmadi-Abhari, Piotr Bandosz, Abbas Dehghan, Paul Elliott
Förderung
- Wellcome Trust
- NIA NIH HHS
- Imperial College London
- European Institute of Innovation and Technology
- Medical Research Council
- Alzheimer’s Research UK
- Academy of Finland
Zitieren
APA
Ahmadi-Abhari, S., Bandosz, P., Shipley, M. J., Lindbohm, J. V., Dehghan, A., Elliott, P., & Kivimaki, M. (2025). Direct and indirect impacts of the COVID-19 pandemic on life expectancy and person-years of life lost with and without disability: A systematic analysis for 18 European countries, 2020–2022. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1004541
Vancouver
Ahmadi-Abhari S, Bandosz P, Shipley MJ, Lindbohm JV, Dehghan A, Elliott P, et al. Direct and indirect impacts of the COVID-19 pandemic on life expectancy and person-years of life lost with and without disability: A systematic analysis for 18 European countries, 2020–2022. PLOS Medicine. 2025. doi:10.1371/journal.pmed.1004541
BibTeX
@article{AhmadiAbhari2025,
author = {Ahmadi-Abhari, Sara and Bandosz, Piotr and Shipley, Martin J and Lindbohm, Joni V and Dehghan, Abbas and Elliott, Paul and Kivimaki, Mika},
title = {Direct and indirect impacts of the COVID-19 pandemic on life expectancy and person-years of life lost with and without disability: A systematic analysis for 18 European countries, 2020–2022},
journal = {PLOS Medicine},
year = {2025},
doi = {10.1371/journal.pmed.1004541}
}
EUVIMED